
Sign up to save your podcasts
Or


Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.
By The Lancet OncologyAndre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.